TRIMETOP

This brand name is authorized in Estonia, Lithuania, Malta

Active ingredients

The drug TRIMETOP contains one active pharmaceutical ingredient (API):

1 Trimethoprim
UNII AN164J8Y0X - TRIMETHOPRIM

Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells.

Read about Trimethoprim

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01EA01 Trimethoprim J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EA Trimethoprim and derivatives
Discover more medicines within J01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1016312, 1068465
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1009966, 1009967, 1009968, 1009969
Country: MT Medicines Authority Identifier(s): AA565/79401

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.